Quarterly report · Q2
6545.TEDINET S100S1Q2
Period2023-04-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.4bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥4.5bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.1bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥60m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥35m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥72m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥146m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥53m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥66m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥46m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥34m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥34m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥27m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥34m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥27m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥3.3bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥3.2bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥2.9bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.0bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥1.9bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.3bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥1.3bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.3bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.1bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥197m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥303m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥214m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥60m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥302m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥104m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥24m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥59m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥6.37 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.92 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥6.27 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.02 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.05 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥6.21 | 2023-04-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥6.13 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥4.9 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 39.6% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.5% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.5% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥273m |
| jpcrp040300-q2r_E33005-000Health Care Solution Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E33005-000Health Care Solution Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E33005-000Health Care Solution Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥156m |
| jpcrp040300-q2r_E33005-000Home Care Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥772m |
| jpcrp040300-q2r_E33005-000Home Care Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥772m |
| jpcrp040300-q2r_E33005-000Home Care Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥177m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥333m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥265m |
| jpcrp040300-q2r_E33005-000Health Care Solution Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.4bn |
| jpcrp040300-q2r_E33005-000Health Care Solution Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.4bn |
| jpcrp040300-q2r_E33005-000Health Care Solution Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥156m |
| jpcrp040300-q2r_E33005-000Home Care Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥638m |
| jpcrp040300-q2r_E33005-000Home Care Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥638m |
| jpcrp040300-q2r_E33005-000Home Care Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥144m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥2.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥2.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥300m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 456
| Item | Context | Value | Unit |
|---|---|---|---|
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |